RE
BLU

RBC Europe’s BELLUS Health Inc. BLU Stock Holding History

RBC Europe’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,200
Closed -$25.8K – 1225
2021
Q3 		$25.8K Hold
4,200
– – ﹤0.01% 722
2021
Q2 		$13.1K Hold
4,200
– – ﹤0.01% 902
2021
Q1 		$16.1K Hold
4,200
– – ﹤0.01% 820
2020
Q4 		$12.9K Hold
4,200
– – ﹤0.01% 826
2020
Q3 		$9.53K Buy
+4,200
New +$11.9K ﹤0.01% 806

Other funds holding BLU

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

RBC Europe's BLU Position: Q4 2021 in Review

RBC Europe sold out of BELLUS Health Inc. (BLU) in Q4 2021, closing a stake of 4,200 shares — an estimated $25.8K sold.

RBC Europe first reported a position in BLU in Q3 2020 and held it in 5 quarters. The position peaked at $25.8K in Q3 2021. 89 funds tracked by Wall St. Rank hold BLU as of Q4 2021.

  • RBC Europe reported no remaining BELLUS Health Inc. position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 4,200 BELLUS Health Inc. shares in Q4 2021, an estimated $25.8K.
  • RBC Europe first reported a position in BELLUS Health Inc. in Q3 2020 and held it in 5 quarters.
  • RBC Europe's BELLUS Health Inc. position peaked at $25.8K in Q3 2021.
  • 89 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.